| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |